Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
Open Access
- 26 July 2009
- journal article
- review article
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2009, 1-6
Abstract
The contribution of adipose tissue an autocrine and endocrine organ in the pathogenesis of infectious disease and metabolic syndrome is gaining attention. Adipose tissue and adipocytes are one of the major targets ofT. cruziinfection. Parasites are detected 300 days postinfection in adipose tissue. Infection of adipose tissue and cultured adipocytes triggered local expression of inflammatory mediators resulting in the upregulation of cytokine and chemokine levels. Adipose tissue obtained from infected mice display an increased infiltration of inflammatory cells. Adiponectin, an adipocyte specific protein, which exerts antiinflammatory effects, is reduced during the acute phase of infection. The antiinflammatory regulator peroxisome proliferator activated receptor-(PPAR-) is downregulated in infected cultured adipocytes and adipose tissue.T. cruziinfection is associated with an upregulation of signaling pathways such as MAPKs, Notch and cyclin D, and reduced caveolin-1 expression. Adiponectin null mice have a cardiomyopathy and thus we speculate that theT. cruzi-induced reduction in adiponectin contributes to theT. cruzi-induced cardiomyopathy. WhileT. cruziinfection causes hypoglycemia which correlates with mortality, hyperglycemia is associated with increased parasitemia and mortality. TheT. cruzi-induced increase in macrophages in adipose tissue taken together with the reduction in adiponectin and the associated cardiomyopathy is reminiscent of the metabolic syndrome.
Keywords
Funding Information
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
- National Institutes of Health (HL-73732, AI-076248, 06538, AI-052739, R01-DK55758, R01-CA112023, P60DK020541)
This publication has 49 references indexed in Scilit:
- Adipocyte metabolism and obesityJournal of Lipid Research, 2009
- The Adipocyte as an Endocrine CellEndocrinology and Metabolism Clinics of North America, 2008
- Obesity-associated improvements in metabolic profile through expansion of adipose tissueJournal of Clinical Investigation, 2007
- Adipocyte, Adipose Tissue, and Infectious DiseaseInfection and Immunity, 2007
- Mouse models of lipodystrophy: Key reagents for the understanding of the metabolic syndromeDrug Discovery Today: Disease Models, 2007
- Inflammation and metabolic disordersNature, 2006
- Cardioprotection by AdiponectinTrends in Cardiovascular Medicine, 2006
- Tumor necrosis factor-α stimulates HIV-1 production in primary culture of human adipocytesExperimental Cell Research, 2005
- Hormonal Regulation of Adiponectin Gene Expression in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 2002
- Parasitism of adipocytes by Trypanosoma cruziMemórias do Instituto Oswaldo Cruz, 1995